Rasagiline

CHEMBL887 Phase 4 Zugelassen Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

171.2 g/mol

LogP

1.8

Phase

4

A MAO-B inhibitor used to treat Parkinson's disease, either alone in early stages or combined with levodopa in more advanced disease, by increasing dopamine levels in the brain. It may also have neuroprotective properties that could slow disease progression.

Molekularmasse

171,2400 g/mol

LogP

1,80

TPSA

12,00 Å²

Lipinski-Regel der Fünf

Bestanden

Therapeutische Bereiche

Alzheimer's Disease Parkinson's Disease Schizophrenia Major Depressive Disorder

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D-Struktur

SVG PNG

Cite this structure

Embed this structure

SMILES

C#CCN[C@@H]1CCc2ccccc21

InChI

InChI=1S/C12H13N/c1-2-9-13-12-8-7-10-5-3-4-6-11(10)12/h1,3-6,12-13H,7-9H2/t12-/m1/s1

Molecular Formula

C12H13N

HBD / HBA

1 / 1

Rotierbare Bindungen

2

Schwere Atome

13

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Häufig gestellte Fragen

A MAO-B inhibitor used to treat Parkinson's disease, either alone in early stages or combined with levodopa in more advanced disease, by increasing dopamine levels in the brain. It may also have neuroprotective properties that could slow disease progression.

Yes, Rasagiline is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL887. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 3052776. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Suchen Sie patientenfreundliche Informationen?

Rasagiline auf PillFYI

Struktur

Schnelldaten

Formel: C12H13N
Synonyme: 1

Externe Links

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Medizinischer Haftungsausschluss

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.